Proactive Disclosure

Disclosure of Travel and Hospitality Expenses

Dr. Brien Benoit, Chairperson and CEO

Travel Expenses - June 2, 2006 to September 1, 2006

Date(s) Purpose Total Cost
6/7/2006 to 6/9/2006 Hearing in the matter of Janssen-Ortho Inc. and the medicine Risperdal Consta $45.69
6/20/2006 to 6/20/2006 Executive Committee Meeting $15.23
6/27/2006 to 6/28/2006 Hearing in the matter of Janssen-Ortho Inc. and the medicine Risperdal Consta $30.46
8/8/2006 to 8/8/2006 Hearing in the matter of Shire BioChem Inc. and the medicine Adderall XR $45.69
8/18/2006 to 8/18/2006 Executive Committee Meeting $15.23
Total: $152.30

Hospitality Expenses - June 2, 2006 to September 1, 2006

There are no hospitality expenses for this period.




Please note that information that would normally be withheld under the Access to Information Act or the Privacy Act does not appear on this web site.

Date modified: